Antiinflammatory role of endomorphins in osteoarthritis, rheumatoid arthritis, and adjuvant‐induced polyarthritis
Open Access
- 31 January 2008
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 58 (2) , 456-466
Abstract
Objective Pain sensitization and the related secretion of neuropeptides from sensory nerve terminals are proinflammatory in osteoarthritis (OA), rheumatoid arthritis (RA), and adjuvant-induced polyarthritis. In contrast, endogenous opioids such as the recently discovered endomorphins (EMs) are antiinflammatory. However, the role of endogenous EMs such as EM-1 and EM-2 has never been investigated in OA and RA. Methods We established a highly sensitive radioimmunoassay to detect EM-1 and EM-2. In patients with RA and patients with OA, immunohistochemistry for EM-1 and EM-2 was performed, and double-staining was used to identify EM-positive cells. The effects of EM-1 and EM-2 on the secretion of interleukin-6 (IL-6) and IL-8 from human synovial tissue were studied by tissue superfusion, and the therapeutic effects of EM-1 were tested in a rat model of adjuvant-induced polyarthritis. Results EM-positive cells were located in the sublining area and vessel walls but were particularly evident in the highly inflamed lining area. Human macrophages, T cells, and fibroblasts stained positive for EMs. The synovial density of EM-positive cells was higher in patients with OA than in those with RA. EM-1 inhibited synovial secretion of IL-6 in patients with RA and secretion of IL-8 in patients with RA and those with OA (maximum 10−10M). EM-2 inhibited IL-8 secretion only from RA tissue (maximum 10−10M). In rats with adjuvant-induced polyarthritis, thymus, spleen, and synovial tissue contained significantly more EM-1 than was observed in controls. Rats with adjuvant-induced polyarthritis benefited from EM-1 treatment. Conclusion EM-1 had antiinflammatory effects in patients with OA or RA and in a model of adjuvant-induced polyarthritis. Local enhancement of EM-1 might be an interesting therapeutic option in different forms of arthritis.Keywords
This publication has 47 references indexed in Scilit:
- Role of peripheral μ‐opioid receptors in arthritis: Are they potential targets for therapy?Arthritis & Rheumatism, 2005
- Chronic arthritis down‐regulates peripheral μ‐opioid receptor expression with concomitant loss of endomorphin 1 antinociceptionArthritis & Rheumatism, 2005
- Expression of functional μ-opioid receptors in human osteoarthritic cartilage and chondrocytesBiochemical and Biophysical Research Communications, 2003
- CALCITONIN GENE-RELATED PEPTIDE II, SUBSTANCE P AND VASOACTIVE INTESTINAL PEPTIDE IN PLASMA AND SYNOVIAL FLUID FROM PATIENTS WITH INFLAMMATORY JOINT DISEASERheumatology, 1993
- Substance P and Somatostatin Levels in Rheumatoid Arthritis, Osteoarthritis, and Psoriatic Arthritis Synovial FluidAnnals of the New York Academy of Sciences, 1991
- Increased calcitonin gene-related peptide (CGRP), substance P, and enkephalin immunoreactivities in dorsal spinal cord and loss of CGRP-immunoreactive motoneurons in arthritic rats depend on intact peripheral nerve supplyJournal of Molecular Neuroscience, 1991
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Brain and spinal cord neuropeptides in adjuvant induced arthritis in ratsLife Sciences, 1987
- Prodynorphin gene expression is enhanced in the spinal cord of chronic arthritic ratsNeuroscience Letters, 1987
- Beta-endorphin, immunological and biochemical changes in synovial fluid in rheumatic disordersClinical Rheumatology, 1986